What types of adverse reactions were reported when taking Technivie? | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Technivie (ombitasvir, paritaprevir, and ritonavir)

What types of adverse reactions were reported when taking Technivie?

UPDATE: AbbVie discontinued Technivie effective December 31, 2018.

In clinical studies of Technivie and ribavirin, the most commonly reported side effects (> 10% of subjects) were asthenia (weakness), fatigue, nausea and insomnia.

Last Updated: December 2018

Bristol-Myers wins approval for 1st hepatitis C type 3 drug. http://www.washingtontimes.com/news/2015/jul/24/bristol-myers-wins-approval-for-1st-hepatitis-c-ty/, The Washington Times. Retrieved July 28, 2015.

Highlights of Prescribing Information - TECHNIVIE. http://rxabbvie.com/pdf/technivie_pi.pdf, AbbVie, Inc. Retrieved July 28, 2015.